| Literature DB >> 35176050 |
Alexandra F Jamison1, Benjamin J J McCormick2, Ejaz Hussain3, Elizabeth D Thomas1, Syed Iqbal Azam4, Chelsea L Hansen1, Zeba A Rasmussen1.
Abstract
The incidence of vaccine preventable disease in Pakistan remains high despite a long-standing Expanded Program on Immunization (EPI). We describe vaccine completeness, timeliness and determinants of coverage from a remote rural cohort (2012-2014). Vaccination histories were taken from EPI records. Vaccination was complete if all doses were received according to the EPI schedule and timely if doses were not ≥3 days early or ≥ 28 days late. Three models are presented: a multivariable logistic regression of household demographic and socioeconomic factors associated with complete vaccination, a multivariable mixed effects logistic regression assessing whether or not the vaccine was administered late (versus on-time), and a mixed effects multivariable Poisson regression model analysing the interval (in days) between vaccine doses. Of 959 enrolled children with full vaccination histories, 88.2 and 65.1% were fully vaccinated following either the pentavalent or DPT/HBV schedules if measles was excluded; coverage dropped to 50.0 and 27.1% when both doses of measles were included. Sixty-four (6.7%) were unvaccinated. Coverage and timeliness declined with subsequent doses. Migrating into the village after 1995 (95%CI 1.88 to 5.17) was associated with late vaccination. Being male, having an older father, and having parents with at least some formal education reduced the likelihood of a late dose. The interval between doses was consistent at 5 weeks (compared with the 4 weeks recommended by EPI). None of the socio-demographic variables were related to the likelihood of receiving full coverage. Vaccine coverage in Oshikhandass was higher than national averages. Measles vaccine coverage and timeliness were low; special consideration should be paid to this vaccine. The local vaccination schedule differed from the EPI, but the consistency suggests good local administration.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35176050 PMCID: PMC8853560 DOI: 10.1371/journal.pone.0263712
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Household and demographic characteristics of the population (N = 959 children).
| Migration into village | |||
|---|---|---|---|
| Before 1995 | After 1995 |
| |
| N | 722 | 225 | |
|
| |||
| Child order | 2 [1, 4] | 3 [2, 5] | <0.001 |
| Total number of children | 3 [2, 4] | 4 [3, 6] | <0.001 |
| Maternal age (y) | 27 [24, 31] | 28 [24, 32] | 0.041 |
| Paternal age (y) | 32 [28, 36] | 33 [28, 37] | 0.185 |
| Family income (Rupees) | 41169 (85727) | 21407 (21303) | 0.003 |
| Distance to dispensary (km) | 1.07 [0.76, 1.33] | 1.14 [0.86, 1.53] | <0.001 |
|
| |||
| Sex of child (male) | 383 (53.0) | 125 (55.6) | 0.56 |
| Maternal education (some) | 590 (81.8) | 114 (50.7) | <0.001 |
| Paternal education (some)) | 668 (92.6) | 187 (83.1) | <0.001 |
| Knowledge of germs as cause of diarrhea/pneumonia (y) | 468 (68.4) | 121 (58.7) | 0.013 |
1Education was classified as some or no formal education
2 Kruskal-Wallis test
3 t-test
4 χ2 test
Vaccine coverage and timeliness (N (%)) for the n = 959 children with complete vaccination histories.
DPT and HBV (n = 155) were replaced with the pentavalent vaccine (n = 740) part way through the study hence children were eligible for one or other. Timeliness assumes a vaccine should be given within a -3≤ days ≤ 28 window around the EPI schedule.
| Vaccine | Dose | Target age | Coverage | Timing | |||
|---|---|---|---|---|---|---|---|
| Received | Not Received | Early | On Time | Late | |||
| (<-3 days) | (3≤ EPI ≤28) | (>28 days) | |||||
| BCG | 1 | Birth | 916 (95.5) | 43 (4.5) | - | 730 (79.7) | 186 (20.3) |
| OPV | 1 | Birth | 853 (88.9) | 106 (11.1) | - | 687 (80.5) | 166 (19.5) |
| 2 | 6w | 899 (93.7) | 60 (6.3) | 51 (5.7) | 675 (75.1) | 173 (19.2) | |
| 3 | 10w | 880 (91.8) | 79 (8.2) | 28 (3.2) | 523 (59.4) | 329 (37.4) | |
| 4 | 14w | 847 (88.3) | 112 (11.7) | 17 (2.0) | 344 (40.6) | 486 (57.4) | |
| DPT | 1 | 6w | 155 (100) | 0 (0) | 11 (7.1) | 104 (67.1) | 40 (25.8) |
| 2 | 10w | 153 (98.7) | 2 (1.3) | 4 (2.6) | 89 (58.2) | 60 (39.2) | |
| 3 | 14w | 149 (96.1) | 6 (3.9) | 2 (1.3) | 60 (40.3) | 87 (58.4) | |
| HBV | 1 | 6w | 124 (80.0) | 31 (20.0) | 9 (7.3) | 87 (70.2) | 28 (22.6) |
| 2 | 10w | 122 (78.7) | 33 (21.3) | 3 (2.5) | 79 (64.8) | 40 (32.8) | |
| 3 | 14w | 120 (77.4) | 35 (22.6) | 1 (0.8) | 55 (45.8) | 64 (53.3) | |
| Pentavalent | 1 | 6w | 740 (100) | 0 (0) | 43 (5.8) | 563 (76.1) | 134 (18.1) |
| 2 | 10w | 722 (97.6) | 18 (2.4) | 27 (3.7) | 426 (59.0) | 269 (37.3) | |
| 3 | 14w | 690 (93.2) | 50 (6.8) | 17 (2.5) | 278 (40.3) | 395 (57.2) | |
| Measles | 1 | 9mo | 738 (77.0) | 221 (23.0) | 71 (9.6) | 353 (47.9) | 314 (42.5) |
| 2 | 15mo | 467 (48.7) | 492 (51.3) | 249 (53.3) | 59 (12.6) | 159 (34.0) | |
a n = 155
b = 740